Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A McSweeney

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Hematology Reports|December 30, 2003
Treatment options for newly diagnosed patients with chronic myeloid leukemiaLori J Maness, Peter A McSweeney
Current Opinion in Oncology|August 23, 2002
Reduced-intensity allogeneic transplantation for lymphomaKaren E Kogel, Peter A McSweeney
Best Practice & Research. Clinical Haematology|August 11, 2004
High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosisJacob M van Laar, Peter A McSweeney
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical reviewHarry Openshaw, Richard A Nash, Peter A McSweeney
Hematology. American Society of Hematology. Education Program|November 25, 2003
Hematopoietic cell transplantation for benign hematological disorders and solid tumorsRainer F Storb, Guido Lucarelli, Peter A McSweeney, et al.
Veterinary Immunology and Immunopathology|July 21, 2004
Isolation and characterization of pediatric canine bone marrow CD34+ cellsSteven E Suter, Terry A Gouthro, Peter A McSweeney, et al.
British Journal of Haematology|November 18, 2003
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantationChristian Junghanss, Rainer Storb, Michael B Maris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control studyChristian Junghanss, Kieren A Marr, Rachel A Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipientsMichelle A Barron, Dexiang Gao, Kathryn L Springer, et al.
Cancer|March 4, 2008
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantationMohamed Sorror, Barry Storer, Brenda M Sandmaier, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Hematology Reports|December 30, 2003
Treatment options for newly diagnosed patients with chronic myeloid leukemiaLori J Maness, Peter A McSweeney
Current Opinion in Oncology|August 23, 2002
Reduced-intensity allogeneic transplantation for lymphomaKaren E Kogel, Peter A McSweeney
Best Practice & Research. Clinical Haematology|August 11, 2004
High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosisJacob M van Laar, Peter A McSweeney
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2002
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical reviewHarry Openshaw, Richard A Nash, Peter A McSweeney
Hematology. American Society of Hematology. Education Program|November 25, 2003
Hematopoietic cell transplantation for benign hematological disorders and solid tumorsRainer F Storb, Guido Lucarelli, Peter A McSweeney, et al.
Veterinary Immunology and Immunopathology|July 21, 2004
Isolation and characterization of pediatric canine bone marrow CD34+ cellsSteven E Suter, Terry A Gouthro, Peter A McSweeney, et al.
British Journal of Haematology|November 18, 2003
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantationChristian Junghanss, Rainer Storb, Michael B Maris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control studyChristian Junghanss, Kieren A Marr, Rachel A Carter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipientsMichelle A Barron, Dexiang Gao, Kathryn L Springer, et al.
Cancer|March 4, 2008
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantationMohamed Sorror, Barry Storer, Brenda M Sandmaier, et al.
Pageof 6